Hepatitis C Virus Therapy
Scientists at Okayama University release new data on hepatitis C virus therapy
Published in Hepatitis Weekly, May 18th, 2009
A report, 'Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience,' is newly published data in Liver International. According to recent research from Okayama, Japan, "Adherence to combination therapy with interferon (IFN) or pegylated IFN plus ribavirin for chronic hepatitis C patients is important for a better virological response. However, the impact of the patient's treatment experience and treatment centre on adherence to combination therapy has not been fully analysed."
"In this prospective study, we analysed the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-05-18)
More Articles from Hepatitis Weekly
- Hepatitis A Virus
New hepatitis A virus study results from E. Robesyn et al described - Hepatitis B Virus
Data on hepatitis B virus detailed by W.W. Chen and co-authors - Hepatitis B Virus
Findings from M. Pozzi et al in hepatitis B virus reported - Hepatitis B Virus
New hepatitis B virus study findings have been published by J. Lupo and colleagues - Hepatitis B Virus
New hepatitis B virus study findings recently were reported by researchers at Brown University - Hepatitis B Virus
New hepatitis B virus study results reported from Sichuan University - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
